BeiGene, Ltd. (ONC)
NASDAQ: ONC · Real-Time Price · USD
233.25
+1.26 (0.54%)
At close: May 12, 2025, 4:00 PM
233.25
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
BeiGene Market Cap
BeiGene has a market cap or net worth of $25.13 billion as of May 12, 2025. Its market cap has increased by 66.80% in one year.
Market Cap
25.13B
Enterprise Value
23.53B
1-Year Change
66.80%
Ranking
Category
Stock Price
$233.25
Market Cap Chart
Since February 3, 2016, BeiGene's market cap has increased from $861.90M to $25.13B, an increase of 2,815.91%. That is a compound annual growth rate of 43.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 25.04B | 27.16% |
| Dec 31, 2024 | 19.69B | 4.41% |
| Dec 29, 2023 | 18.86B | -17.40% |
| Dec 30, 2022 | 22.83B | -10.17% |
| Dec 31, 2021 | 25.41B | 8.12% |
| Dec 31, 2020 | 23.50B | 133.90% |
| Dec 31, 2019 | 10.05B | 20.62% |
| Dec 31, 2018 | 8.33B | 87.56% |
| Dec 29, 2017 | 4.44B | 342.97% |
| Dec 30, 2016 | 1.00B | 16.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |